Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2001, p. 834-839, Vol. 67, No. 2
Dipartimento di Patologia Sperimentale,
Biotecnologie Mediche, Infettivologia ed Epidemiologia,
Università degli Studi di Pisa, Pisa, Italy
Received 28 September 2000/Accepted 28 November 2000
A substantial number of Bacillus species have been
marketed for use in oral bacteriotherapy because of their purported
ability to prevent or treat various gastrointestinal disorders.
Recently, some of the Bacillus strains in Enterogermina,
which is made up of aqueous suspensions of viable Bacillus
spores, have been partially characterized and aligned with members of
the Bacillus alcalophilus subgroup rather than with
Bacillus subtilis, as previously reported. With a view
toward verifying the original taxonomic position of the Enterogermina
strains, we catalogued both phenotypic and genotypic traits exhibited
by the four Bacillus strains isolated from the spore
mixtures found in original commercial preparations dated 1975 and 1984 and commercial preparations now being propagated industrially. Analyses
of physiological and biochemical traits, complete 16S rRNA gene
sequences, DNA-DNA reassociation, tRNA intergenic spacer length
polymorphism, single-strand conformation polymorphism of PCR-amplified
spacer regions of tRNA genes, and randomly amplified polymorphic DNA
led to the finding that all of the Enterogermina strains belong to a
unique genospecies, which is unequivocally identified as the
alkalitolerant species Bacillus clausii. Moreover, we
provide evidence that in contrast to several reference strains of
B. clausii, the strains constituting Enterogermina are
characterized by a notable low level of intraspecific genome diversity
and that each strain has remained the same for the last 25 years.
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.2.834-839.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Characterization and Identification of
Bacillus clausii Strains Marketed for Use in Oral
Bacteriotherapy
*
Corresponding author. Mailing address: Dipartimento di
Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed
Epidemiologia, Università degli Studi di Pisa, Via San Zeno
35-39, 56127 Pisa, Italy. Phone: (39) 050 836566. Fax: (39) 050 836570. E-mail: senesi{at}biomed.unipi.it.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»